搜尋結果
Clinical Trial Of Ketamine Tablets Shows Promising Results For Treatment-Resistant Depression
Forbes· 16 小時前A phase 2 clinical trial of 231 patients with treatment-resistant depression found that the ...
Cincinnati Children’s Is A Unicorn, But It Should Be A Role Model
Forbes· 16 小時前At a recent government-sponsored webinar, for instance, Dr. Stephen Muething, the hospital’s ...
Doctor's recommendation does not bar patient's lawsuit over device -California top ...
Reuters· 4 日前A patient may be able to pursue a claim against a drug or medical device maker for failing to ...
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of ...
CNBC· 4 日前If cleared by the Food and Drug Administration, the company plans to launch Zepbound for ...
Council Post: A Paradigm Shift For Healthtech CEOs: Increasing Patient Satisfaction And ...
Forbes· 2 日前In our hyperconnected world, seamless communication is the norm. Having witnessed the ...
Ohio Regulators Approve First Recreational Marijuana Sales Licenses
Forbes· 2 日前Ohio marijuana regulators have issued dozens of provisional licenses to sell recreational ...
At least 2,000 medical evacuations from Gaza prevented by Rafah crossing closure, says WHO
Reuters· 8 小時前The closure of the Rafah crossing between Egypt and Gaza has prevented the medical evacuations ...
58% Of Patients Discontinue Use Of Obesity Meds Before Reaching Meaningful Weight Loss, Study ...
Forbes· 6 日前There is high demand for obesity medications known as glucagon-like peptide-1 agonists, or GLP-1s. In conjunction with an ...
Weight-loss drug Zepbound resolves sleep apnea in up to 52% of patients, Lilly says
Reuters· 4 日前, opens new tab on Friday said its popular weight-loss drug Zepbound helped resolve moderate to ...
North Carolina Senate Approves Medical Marijuana Legalization Bill
Forbes· 5 日前The North Carolina Senate on Thursday approved a bill to legalize medical marijuana, only one ...